Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ischemic Attack, Transient | 8 | 1999 | 167 | 0.390 |
Why?
|
| Subarachnoid Hemorrhage | 10 | 2000 | 61 | 0.380 |
Why?
|
| Ethics | 1 | 2011 | 17 | 0.380 |
Why?
|
| Policy | 1 | 2011 | 58 | 0.370 |
Why?
|
| Cadaver | 1 | 2011 | 136 | 0.360 |
Why?
|
| Coronary Vessels | 2 | 2002 | 313 | 0.330 |
Why?
|
| Heart | 9 | 1984 | 850 | 0.310 |
Why?
|
| Collagen | 9 | 1992 | 636 | 0.300 |
Why?
|
| Chick Embryo | 9 | 2001 | 379 | 0.270 |
Why?
|
| Endothelium, Vascular | 3 | 2002 | 371 | 0.250 |
Why?
|
| Cytoplasm | 1 | 2005 | 155 | 0.250 |
Why?
|
| Angioplasty, Balloon | 3 | 1999 | 110 | 0.240 |
Why?
|
| Pericardium | 1 | 2002 | 97 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 1 | 2002 | 164 | 0.190 |
Why?
|
| Hyaluronic Acid | 4 | 1984 | 206 | 0.180 |
Why?
|
| Fibroblasts | 7 | 1993 | 902 | 0.180 |
Why?
|
| Apoptosis | 3 | 2001 | 1641 | 0.170 |
Why?
|
| Myocardium | 6 | 1984 | 1204 | 0.150 |
Why?
|
| Cerebral Arteries | 3 | 1998 | 50 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 1999 | 317 | 0.120 |
Why?
|
| Animals | 16 | 2005 | 20881 | 0.100 |
Why?
|
| Intracranial Aneurysm | 5 | 2000 | 87 | 0.100 |
Why?
|
| Chondroitin | 2 | 1984 | 13 | 0.100 |
Why?
|
| Chondroitin Sulfates | 2 | 1984 | 44 | 0.100 |
Why?
|
| Aorta | 3 | 2002 | 316 | 0.100 |
Why?
|
| Cells, Cultured | 10 | 1999 | 2673 | 0.100 |
Why?
|
| Vasospasm, Intracranial | 2 | 2000 | 16 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 1990 | 107 | 0.080 |
Why?
|
| Microscopy, Electron | 5 | 2001 | 351 | 0.080 |
Why?
|
| Growth Substances | 2 | 2002 | 77 | 0.080 |
Why?
|
| Glycosaminoglycans | 2 | 1979 | 88 | 0.080 |
Why?
|
| Arteries | 2 | 2002 | 108 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 127 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 1992 | 236 | 0.060 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1984 | 43 | 0.060 |
Why?
|
| Humans | 15 | 2011 | 68618 | 0.060 |
Why?
|
| Endocardium | 2 | 1982 | 101 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2001 | 160 | 0.060 |
Why?
|
| Middle Cerebral Artery | 2 | 2000 | 57 | 0.050 |
Why?
|
| Veins | 1 | 2002 | 68 | 0.050 |
Why?
|
| Aneurysm, Ruptured | 2 | 2000 | 40 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 1984 | 597 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 1996 | 493 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2001 | 133 | 0.040 |
Why?
|
| Oxyhemoglobins | 1 | 1999 | 3 | 0.040 |
Why?
|
| Carbohydrates | 1 | 1979 | 57 | 0.040 |
Why?
|
| Craniocerebral Trauma | 1 | 1999 | 50 | 0.040 |
Why?
|
| Ophthalmic Artery | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 182 | 0.040 |
Why?
|
| Cell Movement | 4 | 1982 | 630 | 0.030 |
Why?
|
| Vasoconstriction | 2 | 1993 | 81 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1996 | 270 | 0.030 |
Why?
|
| Morphogenesis | 3 | 1982 | 159 | 0.030 |
Why?
|
| Cytoskeleton | 2 | 1989 | 84 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 219 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 1999 | 665 | 0.030 |
Why?
|
| Kinetics | 2 | 1984 | 1047 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1990 | 358 | 0.030 |
Why?
|
| Haplorhini | 1 | 1992 | 44 | 0.030 |
Why?
|
| Female | 8 | 2000 | 38074 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1992 | 45 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 1992 | 17 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1993 | 284 | 0.030 |
Why?
|
| Endothelins | 1 | 1992 | 57 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1992 | 138 | 0.020 |
Why?
|
| Cats | 1 | 1992 | 292 | 0.020 |
Why?
|
| Femoral Artery | 1 | 1992 | 139 | 0.020 |
Why?
|
| Heparin | 1 | 1992 | 205 | 0.020 |
Why?
|
| Middle Aged | 6 | 2000 | 21147 | 0.020 |
Why?
|
| Cerebral Angiography | 2 | 1999 | 151 | 0.020 |
Why?
|
| Skin Abnormalities | 1 | 1986 | 11 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 1986 | 45 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 1986 | 166 | 0.020 |
Why?
|
| DNA | 1 | 1989 | 597 | 0.020 |
Why?
|
| Rats | 3 | 1979 | 5300 | 0.020 |
Why?
|
| Proteins | 1 | 1989 | 474 | 0.020 |
Why?
|
| Calcium | 1 | 1989 | 929 | 0.020 |
Why?
|
| Tritium | 1 | 1984 | 101 | 0.020 |
Why?
|
| Male | 4 | 1999 | 37321 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1984 | 165 | 0.020 |
Why?
|
| Wound Healing | 1 | 1986 | 260 | 0.020 |
Why?
|
| Muscles | 1 | 1984 | 158 | 0.010 |
Why?
|
| Endothelium | 1 | 1984 | 98 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 1984 | 142 | 0.010 |
Why?
|
| Aged | 3 | 1999 | 14862 | 0.010 |
Why?
|
| Heart Atria | 1 | 1982 | 206 | 0.010 |
Why?
|
| Anterior Cerebral Artery | 1 | 2000 | 5 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1999 | 32 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 39 | 0.010 |
Why?
|
| Nucleosomes | 1 | 1999 | 25 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 85 | 0.010 |
Why?
|
| Glasgow Coma Scale | 1 | 1999 | 65 | 0.010 |
Why?
|
| Clone Cells | 1 | 1999 | 67 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1979 | 149 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 272 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1999 | 58 | 0.010 |
Why?
|
| Autopsy | 1 | 1999 | 56 | 0.010 |
Why?
|
| Diazooxonorleucine | 1 | 1979 | 3 | 0.010 |
Why?
|
| Cell Count | 1 | 1999 | 248 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1979 | 121 | 0.010 |
Why?
|
| Necrosis | 1 | 1999 | 239 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 1999 | 99 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 475 | 0.010 |
Why?
|
| Cell Death | 1 | 1999 | 329 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1999 | 305 | 0.010 |
Why?
|
| Radiography | 1 | 1999 | 572 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1979 | 324 | 0.010 |
Why?
|
| Models, Biological | 1 | 1982 | 981 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1978 | 41 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1998 | 164 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1998 | 85 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1982 | 738 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 954 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1979 | 525 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1996 | 11 | 0.010 |
Why?
|
| Colforsin | 1 | 1996 | 42 | 0.010 |
Why?
|
| Diglycerides | 1 | 1996 | 49 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1996 | 23 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 1996 | 94 | 0.010 |
Why?
|
| Time Factors | 2 | 1999 | 4655 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 1745 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1996 | 791 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 659 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1990 | 21 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1998 | 2324 | 0.000 |
Why?
|
| Risk Factors | 1 | 1998 | 5731 | 0.000 |
Why?
|
| Adult | 2 | 1999 | 21403 | 0.000 |
Why?
|
| Adolescent | 1 | 1999 | 8912 | 0.000 |
Why?
|
| Reference Values | 1 | 1986 | 579 | 0.000 |
Why?
|
| Skin | 1 | 1986 | 451 | 0.000 |
Why?
|
| Mice | 1 | 1986 | 8474 | 0.000 |
Why?
|